Brachytherapy Devices Market Report – Predicted To Expand At 2.3% CAGR In Future

The brachytherapy devices market is predicted to expand at about 2.3% CAGR in the coming years. This expansion owes to increasing cancer patients globally. Brachytherapy is used for prostate, cervical, skin and breast cancers. The pivotal factors driving the brachytherapy devices market are cost effectiveness, shorter span of treatment time and improved efficiency.

However alternative methods for treating cancer are likely to hamper the market over the coming years. The brachytherapy devices market can be fragmented into products and geographies. The products market can be segmented into breast irradiation, prostate seeds and macular degeneration. Macular degeneration accounts for the largest share in the brachytherapy devices market.

Geographically, the brachytherapy devices market can be segregated into four major regions, including North America, Europe, Asia Pacific and ROW (rest of the world). North America accounted for the largest share in the brachytherapy devices market. This is due to rising chronic diseases, like kidney ailments and cancer in the region.

The developing economies of Asia Pacific, especially China and India are the fastest growing brachytherapy devices market regions. Rising demand for brachytherapy devices in these regions is propelled by augmented health awareness and technical advancements. This trend is expected to continue over the coming years as a result of an increased aged population seeking cancer treatments.

Brachytherapy devices are creating huge opportunity for less or non-invasive outpatient methods. These methods can be modified according to various requirements of the patients. Improving infrastructure facilities and developing medical sectors also drive further demand for the brachytherapy devices market.